DrugPatentWatch

DrugPatentWatch Archives

You are currently viewing the 2009 archives
Click here to return to the current data set

Competitive intelligence on small-molecule drugs and the 80,000 patents covering them

Simple flat-rate subscription plans

Ultimate Plan

$495/ month or  $2,495/ year

Tradename: DIFFERIN

Summary for Tradename: DIFFERIN

Patents:3
Applicants:1
NDAs:4
Suppliers: see list6
drug
patent expirations by year for
 DIFFERIN

Pharmacology for Tradename: DIFFERIN

Ingredient-typeRetinoids
Drug ClassRetinoid

Clinical Trials for: DIFFERIN

Tolerability Comparison of Differin® Cream 0.1% Versus Differin® Lotion 0.1% in Subjects With Healthy Skin
Status: Completed Condition: Skin Manifestations

Tolerability Comparison Between Differin® Cream 0.1% Versus Differin® Lotion 0.1% in Subjects With Healthy Skin
Status: Completed Condition: Skin Manifestations

Differin® Gel x12 Wks vs Tazorac® Cream x12 Wks vs Differin® x6 Wks Switched to Tazorac® x6 Wks for Treatment of Acne
Status: Completed Condition: Acne Vulgaris

Pharmacokinetic Study to Compare the Systemic Exposure of Differin® Gel, 0.3% or Differin® Gel, 0.1%
Status: Completed Condition: Acne Vulgaris

A Study Comparing Aczone® Plus Differin® Versus Duac® Plus Differin® in Patients With Severe Facial Acne
Status: Completed Condition: Acne Vulgaris

Study Comparing 0.3% Adapalene Topical Gel to Differin® 0.3% Adapalene Topical Gel
Status: Completed Condition: Acne Vulgaris

Evaluation of Quality of Life, Efficacy, and Tolerance of Duac® Gel Compared to Differin® Gel in the Treatment of Acne
Status: Completed Condition: Acne Vulgaris

A Comparative Study of Adapalene Gel,0.3% Versus Tretinoin Emollient Cream, 0.05% for the Treatment of Photoaging
Status: Recruiting Condition: Photoaging; Photodamage

Bioequivalence of Adapalene Topical Gel in Patients With Acne Vulgaris
Status: Completed Condition: Acne Vulgaris

Pharmacokinetics Study of Dapsone-Adapalene Fixed Combination Gel in Acne
Status: Withdrawn Condition: Acne Vulgaris

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Galderma Labs Lp
DIFFERIN
adapalene
CREAM; TOPICAL020748May 26, 2000RXYes4,717,720<disabled><disabled>
Galderma Labs Lp
DIFFERIN
adapalene
CREAM; TOPICAL020748May 26, 2000RXYesRE34440<disabled><disabled>
Galderma Labs Lp
DIFFERIN
adapalene
GEL; TOPICAL020380May 31, 1996RXYes4,717,720<disabled><disabled>
Galderma Labs Lp
DIFFERIN
adapalene
GEL; TOPICAL020380May 31, 1996RXYesRE34440<disabled><disabled>
This preview shows a limited data set
Complete access is available with a Subscription
first patents previous patents next patents last patents

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: DIFFERIN

Drugname Dosage Strength RLD Submissiondate
adapaleneTopical Gel0.30%Differin9/15/2009

« Back to Dashboard

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: BiotechUBiotechBlogJournal of Commercial Biotechnology

`abc